Signal Transduction and Targeted Therapy (Nov 2021)

RBD206-sc-dimer induced robust cross-neutralization against SARS-CoV-2 and variants of concern

Chuge Zhou,
Xiaodong Zai,
Ziqing Zhou,
Ruihua Li,
Yue Zhang,
Yaohui Li,
Ying Yin,
Jun Zhang,
Junjie Xu,
Wei Chen

Affiliations

Chuge Zhou: Beijing Institute of Biotechnology
Xiaodong Zai: Beijing Institute of Biotechnology
Ziqing Zhou: Beijing Institute of Biotechnology
Ruihua Li: Beijing Institute of Biotechnology
Yue Zhang: Beijing Institute of Biotechnology
Yaohui Li: Beijing Institute of Biotechnology
Ying Yin: Beijing Institute of Biotechnology
Jun Zhang: Beijing Institute of Biotechnology
Junjie Xu: Beijing Institute of Biotechnology
Wei Chen: Beijing Institute of Biotechnology

DOI: https://doi.org/10.1038/s41392-021-00798-8
Journal volume & issue: Vol. 6, no. 1
pp. 1 – 4

Abstract

No abstracts available.

Published in Signal Transduction and Targeted Therapy

ISSN: 2059-3635 (Online)
Publisher: Nature Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine; Science: Biology (General)
Website: http://www.nature.com/sigtrans/

About the journal